Inventor · disambiguated record
Lihong Hu
Also filed as: HU LIHONG
30 granted patents·24 pending applications·25 citations·filing 2007–2023
93Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD13MEDSHINE DISCOVERY INC12LUOXIN PHARMACEUTICAL SHANGHAI CO LTD4MERCK SHARP & DOHME4JIANGSU AOSAIKANG PHARM CO LTD3
Top patents by PatentIndex Score
54 records- 0181US9643982B2Fused tricyclic heterocyclic compounds as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 9, 2017·3 cites·14 claims
- 0280US11453667B2Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted Sep 27, 2022·2 cites·19 claims
- 0379US11623923B2Uracil compound as c-MET/AXL inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Apr 11, 2023·2 cites·23 claims
- 0479US11358950B2SMAC mimetics used as IAP inhibitors and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jun 14, 2022·2 cites·19 claims
- 0579US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
- 0677US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 0776US11691974B23,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitorsMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 4, 2023·1 cites·7 claims
- 0876US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 0976US9707234B2Spirocyclic hetercycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jul 18, 2017·2 cites·19 claims
- 1072US12221432B2Estrogen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Feb 11, 2025·1 cites·20 claims
- 1171US10654868B2Dihydropyrazole azepine compound serving as Akt inhibitorHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2017·Granted May 19, 2020·1 cites·12 claims
- 1269US10221186B2Spirocyclic heterocyclic compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Mar 5, 2019·1 cites·13 claims
- 1369US9556154B2Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising same and use thereofSHIJIAZHUANG YILING PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 31, 2017·2 cites·20 claims
- 1463US8168647B2Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivativesHU LIHONG·Filed 2007·Granted May 1, 2012·1 cites·4 claims
- 1563US2023339839A1Synthesis method of alpha-hydroxycarboxylic acid esterGUANGXI FORESTRY RES INSTITUTE·Filed 2023·Application pending·0 cites
- 1662US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 1761US2024124409A1Guaianolide sesquiterpene lactone derivatives and pharmaceutical use thereofUNIV NANJING CHINESE MEDICINE·Filed 2023·Application pending·0 cites
- 1861US2025109156A1Indole-containing macrocyclic compounds and uses thereofJIANGSU AOSAIKANG PHARM CO LTD·Filed 2023·Application pending·0 cites
- 1960US11655248B2Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2021·Granted May 23, 2023·0 cites·18 claims
- 2059US2024409543A1Pyrrolopyrazole spiro compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 2157US2024025920A1Salt form used as cdc7 inhibitor and crystal form thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2255US2025268901A1Crystal form of azetidine-substituted compoundMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 2355US2024043401A1Salt form of tetra-substituted olefin compound, crystal, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2454US11718610B2Compounds containing benzosultamMEDSHINE DISCOVERY INC·Filed 2021·Granted Aug 8, 2023·0 cites·20 claims
- 2554US2023331739A1Indolo heptamyl oxime analog crystal as parp inhibitor and method for preparing sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2653US11530196B2Pyrimidine compound acting on EGFR and ERBB2CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2020·Granted Dec 20, 2022·0 cites·7 claims
- 2753US2013325429A1Compounds and Methods for the Treatment of Viral InfectionsUNIV HONG KONG·Filed 2012·Application pending·0 cites
- 2853US2024277677A1Salt form and crystal form thereof of sulfonylurea ring substituted compoundSUZHOU ERYE PHARMACEUTICAL CO·Filed 2022·Application pending·0 cites
- 2952US12018014B2Pyrrole-substituted indolone derivative or pharmaceutically acceptable salts thereof, and preparation method therefor and application thereofSUZHOU GENHOUSE PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 25, 2024·0 cites·9 claims
- 3052US2022235029A1Crystal form of c-met/axl inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3152US2023141887A1Crystal form of diazaspiropyran compoundMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3251US11465986B2Crystal form of c-MET inhibitor and salt form thereof and preparation method thereforFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2019·Granted Oct 11, 2022·0 cites·16 claims
- 3351US2022389026A1Tetracyclic compound used as cdc7 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 3451US2023046018A1Biaryl compound as pan-raf kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3551US2022235068A1Tetracyclic compounds as cdc7 inhibitorsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 3650US2022194959A1Crystal form of egfr inhibitor and preparation method thereofMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3750US2024190861A1Aminopyrimidine compound as cdk2/4/6 triple inhibitorCISEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3849US12325695B25-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitorJIANGSU AOSAIKANG PHARM CO LTD·Filed 2020·Granted Jun 10, 2025·0 cites·19 claims
- 3949US12122780B2Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitorJIANGSU AOSAIKANG PHARM CO LTD·Filed 2020·Granted Oct 22, 2024·0 cites·17 claims
- 4049US11236112B2Crystal form and salt form of TGF-βRI inhibitor and preparation method thereforGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 4148US11261196B2Salt serving as AKT inhibitor and crystal thereofHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 1, 2022·0 cites·20 claims
- 4248US2012149715A1Compounds and methods for the treatment of viral infectionsKAO YI TSUN RICHARD·Filed 2011·Application pending·0 cites
- 4348US2022267321A1Azaindole pyrazole compounds as cdk9 inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 4447US10774081B2Indolo substituted piperidine compound as estrogen receptor down-regulatorLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
- 4547US2022177453A1Crystallization of smac mimic used as iap inhibitor and preparation method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 4647US2022119431A1Salt of egfr inhibitor, crystal form, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 4744US10676474B21,6-naphthyridine derivatives as CDK4/6 inhibitorCSTONE PHARMACEUTICALS·Filed 2017·Granted Jun 9, 2020·0 cites·20 claims
- 4844US2022175917A1Combination of iap inhibitor and immune checkpoint inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 4943US11390625B2Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 19, 2022·0 cites·16 claims
- 5043US11040984B2Quinazoline compound for EGFR inhibitionMEDSHINE DISCOVERY INC·Filed 2017·Granted Jun 22, 2021·0 cites·24 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lihong Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →